Skip to main content
Log in

Anticholinergic burden may increase costs, resource use in older adults with OAB in the UK

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. The study was funded by Astellas Pharma Europe.

Reference

  • Jaggi A, et al. Anticholinergic Burden and Associated Healthcare Resource Utilization in Older Adults with Overactive Bladder. Drugs and Aging : 13 Aug 2021. Available from: URL: https://doi.org/10.1007/s40266-021-00884-0

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anticholinergic burden may increase costs, resource use in older adults with OAB in the UK. PharmacoEcon Outcomes News 885, 1 (2021). https://doi.org/10.1007/s40274-021-07943-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-07943-y

Navigation